sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Asia-Pacific mHealth Market by Devices (Blood Glucose Meters, BP Monitors, Pulse oximetry, Neurological Monitoring, Wearable fitness sensor device and Heart Rate Meters) and Service (Diagnosis, Monitoring, Prevention, Treatment, Wellness and healthcare system) - Opportunity Analysis and Industry Forecast, 2014 - 2020

Asia-Pacific mHealth Market by Devices (Blood Glucose Meters, BP Monitors,...

Home / Categories / Healthcare
Asia-Pacific mHealth Market by Devices (Blood Glucose Meters, BP Monitors, Pulse oximetry, Neurological Monitoring, Wearable fitness sensor device and Heart Rate Meters) and Service (Diagnosis, Monitoring, Prevention, Treatment, Wellness and healthcare system) - Opportunity Analysis and Industry Forecast, 2014 - 2020
Asia-Pacific mHealth Market by Devices...
Report Code
RO1/113/1032

Publish Date
01/Mar/2016

Pages
122
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Market segmentation
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top impacting factors
3.2.2 Top investment pockets

3.3 Porters five forces analysis

3.3.1 Bargaining power of buyers
3.3.2 Bargaining power of supplier
3.3.3 Threat of new entrant
3.3.4 Threat of substitute
3.3.5 Intensity of rivalry

3.4 Value chain analysis

3.4.1 Primary activities
3.4.2 Secondary activities

3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Integration of wireless technologies with portable healthcare devices
3.5.1.2 Increase in incidences of lifestyle diseaseS
3.5.1.3 Cost and convenience Factors
3.5.1.4 Technological integration
3.5.1.5 increasing government initiatives
3.5.1.6 Affordability of smartphones

3.5.2 Restraints

3.5.2.1 Lower adoption accross developing economies
3.5.2.2 Weak reimbursement coverage
3.5.2.3 Technological awareness among the ageing population

3.5.3 Opportunities

3.5.3.1 Untapped market of developing economies
3.5.3.2 Rising Opportunities in the form of bundled services

CHAPTER 4 BY DEVICES

4.1 Blood glucose meter

4.1.1 Key Market Trends
4.1.2 Key Growth Factors and Opportunity
4.1.3 Market Size and Forecast

4.2 BP monitors

4.2.1 Key Market Trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Pulse oximetry

4.3.1 Key market trends
4.3.2 Key growth factors and opportunity
4.3.3 Market size and forecast

4.4 Neurological monitoring

4.4.1 Key market trends
4.4.2 Key growth factors and opportunity
4.4.3 Market size and forecast

4.5 Cardiac monitors

4.5.1 Key market trends
4.5.2 Key growth factors and opportunity
4.5.3 Market size and forecast

4.6 Apnea sleep monitors

4.6.1 Key market trends
4.6.2 Key growth factors and opportunity
4.6.3 Market size and forecast

4.7 Wearable fitness sensor device and heart rate meters

4.7.1 Key market trends
4.7.2 Key growth factors and opportunity
4.7.3 Market size and forecast

4.8 Others

4.8.1 Market Size and Forecast

CHAPTER 5 BY SERVICES

5.1 Prevention

5.1.1 Market size and forecast

5.2 Diagnostic services

5.2.1 Market size and forecast

5.3 Monitoring services

5.3.1 Market size and forecast

5.4 Treatment

5.4.1 Market size and forecast

5.5 Wellness and healthcare system strengthening solutions

5.5.1 Market size and forecast

CHAPTER 6 BY STAKEHOLDERS

6.1 Mobile operators

6.1.1 Market size and forecast

6.2 Device vendors

6.2.1 Market Size and Forecast

6.3 Healthcare providers

6.3.1 Market size and forecast

6.4 Application/ content players

6.4.1 Market size and forecast

CHAPTER 7 BY APPLICATION

7.1 Cardiovascular

7.1.1 Market size and forecast

7.2 Diabetes

7.2.1 Market size and forecast

7.3 Respiratory

7.3.1 Market size and forecast

7.4 Neurology

7.4.1 Market size and forecast

7.5 Others

7.5.1 Market size and forecast

CHAPTER 8 BY COUNTRY

8.1 Overview

8.1.1 Key market trends
8.1.2 Key growth factors and opportunities
8.1.3 Market size and forecast

8.2 Australia

8.2.1 Market Size and Forecast

8.3 China

8.3.1 Market Size and Forecast

8.4 Japan

8.4.1 Market Size and Forecast

8.5 India

8.5.1 Market Size and Forecast

8.6 Rest of Asia-Pacific

8.6.1 Market Size and Forecast

CHAPTER 9 COMPANY PROFILS

9.1 LifeWatch AG

9.1.1 Company overview
9.1.2 LifeWatch AG snapshot
9.1.3 Operating business segment overview
9.1.4 Business performance
9.1.5 Strategic moves and development
9.1.6 SWOT analysis of LifeWatch AG

9.2 Masimo Corporation

9.2.1 Company overview
9.2.2 Masimo Corporation snapshot
9.2.3 Operating business segment overview
9.2.4 Business performance
9.2.5 Strategic moves and developments
9.2.6 SWOT analysis of Masimo Corporation

9.3 Omron healthcare Inc.

9.3.1 Company overview
9.3.2 Omron Healthcare Snapshot
9.3.3 Operating business segment overview
9.3.4 Business performance
9.3.5 Strategic moves and developments
9.3.6 SWOT analysis of Omron Healthcare Inc.

9.4 Philips healthcare (a division of Royal Philips company)

9.4.1 Company overview
9.4.2 Philips Healthcare snapshot
9.4.3 Operating business segment overview
9.4.4 Business performance
9.4.5 Strategic moves and developments
9.4.6 SWOT analysis of Philips Healthcare

9.5 Bayer Healthcare (a division of Bayer)

9.5.1 Company overview
9.5.2 Bayer Healthcare snapshot
9.5.3 Operating business segment overview
9.5.4 Business performance
9.5.5 Strategic moves and development
9.5.6 SWOT analysis Of Bayer Healthcare

9.6 Sanofi

9.6.1 Company overview
9.6.2 Sanofi snapshot
9.6.3 Operating business segment overview
9.6.4 Business performance
9.6.5 Strategic moves and developments
9.6.6 SWOT analysis of Sanofi

9.7 Boston Scientific Corporation

9.7.1 Company overview
9.7.2 Boston Scientific Corporation snapshot
9.7.3 Operating business segment
9.7.4 Business performance
9.7.5 Strategic moves and developments
9.7.6 SWOT analysis of Boston Scientific Corporation

9.8 AT&T Inc.

9.8.1 Company overview
9.8.2 AT&T Inc. snapshot
9.8.3 Operating business segment
9.8.4 Business performance
9.8.5 Strategic moves and developments
9.8.6 SWOT analysis of AT&T Inc.

9.9 Johnson & Johnson

9.9.1 Company overview
9.9.2 Johnson & Johnson Inc snapshot
9.9.3 Operating business segment overview
9.9.4 Business performance
9.9.5 Strategic moves and developments
9.9.6 SWOT analysis of Johnson & Johnson.

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com